single-cell-omics
(4)
Marilyn Matz
Marilyn Matz is the CEO and co-founder of Paradigm4, the Waltham, Massachusetts company behind SciDB, an array-native computational database built for the tangled, multi-dimensional data of genomics, clinical research, and imaging. She launched it in 2010 with database legend and Turing Award laureate Mike Stonebraker to move his MIT research into the hands of working scientists. Decades earlier she left MIT to co-found Cognex, now a global machine-vision powerhouse, where she ran worldwide engineering and later a business unit. A two-time technical founder who codes the deep infrastructure and still sells to the customer, Matz has spent a career making impossibly large scientific data explorable, reproducible, and fast.
LASE Innovation Inc.
LASE Innovation Inc. is a Boston-area techbio company commercializing LP™ Optical Cell Barcoding, a laser-particle technology that tags individual cells with narrowband light signatures tuned across more than 1,000 wavelengths. Spun out of the Wellman Center at Massachusetts General Hospital and MIT, the platform lets researchers run multiple passes of flow cytometry on the same sample, track the same cells over time, and connect single-cell data across flow, imaging and sequencing. The company is turning a long-standing limitation of flow cytometry - that you generally read a cell once and lose it - into a repeatable, trackable measurement.
Daojing Wang
Daojing Wang is the founder, president, and CEO of Newomics, a Berkeley biotech building chip-based mass spectrometry tools for precision medicine. A Princeton-trained chemist who spent 11 years as a principal investigator at Lawrence Berkeley National Laboratory, he co-invented the M3 emitter and multinozzle emitter array (MEA) - a silicon shower-head that makes mass spectrometers far more sensitive. He spun the technology out of the national lab in 2013 and has since shipped well over 100 systems to labs worldwide.
Newomics, Inc.
Newomics is a Berkeley, California biotechnology company building mass spectrometry front-end hardware for precision medicine. Spun out of Lawrence Berkeley National Laboratory, its silicon multinozzle emitter (M3) and MnESI ion source upgrade existing mass spectrometers to deliver microflow robustness with nanospray sensitivity, enabling higher-throughput, higher-sensitivity multiomics across proteomics, metabolomics, lipidomics, native MS and single-cell analysis. The company sells to pharmaceutical, academic and government labs and co-markets with major instrument vendors like Thermo Fisher Scientific.